Results 191 to 200 of about 28,025 (230)

A novel therapy targeting the gut-liver axis for chronic hepatitis B: Ursodeoxycholic acid plus <i>Bifidobacterium</i>. [PDF]

open access: yesJHEP Rep
Xun Z   +19 more
europepmc   +1 more source

Ursodeoxycholic acid alleviates aortic aneurysm and dissection through the intestinal farnesoid X receptor/ceramide synthase 2 axis. [PDF]

open access: yesCommun Biol
Zhang Z   +11 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Ursodeoxycholic Acid

Journal of Gastroenterology and Hepatology, 1996
Abstract  Ursodeoxycholic acid (UDCA) has recently been combined with interferon (IFN) in the treatment of individuals with chronic hepatitis C. However, whether its addition results in a long‐term favourable response to IFN remains unclear. A prospective randomized trial of IFN alone versus IFN plus UDCA was therefore undertaken in 52 patients with ...
KATSUAKI TANAKA   +8 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy